Low megakaryocyte ploidy in Ph-positive chronic myelogenous leukemia measured by flow cytometry

American Journal of Clinical Pathology

Volumn 111, Issue 2, 1999, Pages 185-190

  Jacobsson, Stefan ^b   Wadenvik, Hans ^b   Kutti, Jack ^b   Swolin, Birgitta ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Chronic myelogenous leukemia; Flow cytometry; Megakaryocytes; Ploidy

Indexed keywords

ADULT; AGED; ARTICLE; CELL SIZE; CELL STRUCTURE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FLOW CYTOMETRY; HUMAN; KARYOTYPE; LEUKOCYTE COUNT; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PHILADELPHIA 1 CHROMOSOME; PLOIDY; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 0032900777     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.2.185     Document Type: Article

References (26)

1. Branehög I, Ridell B, Swolin B, et al. Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. Scand J Haematol. 1975;15:321-332.
2. Franzén S, Strenger G, Zajicek J. Microplanimetric studies on megakaryocytcs in chronic granulocytic leukemia and polycythaemia vera. Acta Haematol. 1961;26:182-193.
3. Branehög I, Ridell B, Swolin B, et al. The relation of platelet kinetics to bone marrow megakaryocytes in chronic granulocytic leukemia. Scand J Haematol. 1982;29:411-420.
4. Thiele J, Wagner S, Weuste R, et al. An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML). Eur J Haematol. 1990;44:63-70.
5. Tomer A, Friese P, Conklin R, et al. Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood. 1989;74:594-601.
6. Conklin RJ, Tomer A, Friese P, et al. Flow cytometric analysis of megakaryocytes (Mks) from patients with platelet disorders. In: Breton-Gorius J, Levin J, Nurden AT, et al, eds. Molecular Biology and Differentiation of Megakaryocytes. New York, NY: Wiley-Liss; 1990.
7. Jacobsson S, Carneskog J, Ridell B, et al. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis. Eur J Haematol. 1996;56:287-292.
8. Thiele J, Kvasnicka HM, Niederle N, et al. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study. Am J Hematol. 1995;50:30-39.
9. Tomer A, Harker LA, Burstein SA. Flow cytometric analysis of normal human megakaryocytes. Blood. 1988;71:1244-1252.
10. Rutenburg AM, Rosales CL, Bennett JM. An improved histochemical method for the demonstration of leukocyte alkaline phosphatase activity: clinical application. J Lab Clin Med. 1965;65:698-705.
11. Mitelman F, ed. ISCN 1995 : An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S Karger AG; 1995.
12. Rabellino EM, Bussel JB. Human megakaryocytes, VII: analysis of megakaryocytes for nuclear DNA content distribution in whole marrow cell suspensions by flow cytometry. Exp Hematol. 1990;18:167-173.
13. Ridell B, Kutti J, Revesz P, et al. DNA content and nucleus size of megakaryocytes in thrombocythaemia. APMIS. 1990;98:845-850.
14. Mazur EM, Lindquist DL, de Alarcon PA, et al. Evaluation of bone marrow megakaryocyte ploidy distributions in persons with normal and abnormal platelet counts. J Lab Clin Med. 1988;111:194-202.
15. Renner D, Queisser W. Megakaryocyte polyploidy and maturation in chronic granulocytic leukemia. Acta Haematol. 1988;80:74-78.
16. Kobayashi Y, Ozawa M, Maruo N, et al. Megakaryocytic ploidy in myelodysplastic syndromes. Leuk Lymphoma. 1993;9:55-61.
17. Kobayashi Y, Takahashi Y, Chikayama S, et al. Comparison of the DNA content of megakaryocytes identified immunologically with that identified morphologically. Histochem Cell Biol. 1997;108:115-120.
18. Larramendy ML, Nylund SJ, Wessman M, et al. Ploidy in bone marrow cells from healthy donors: a MAC (morphology antibody chromosomes) study. Br J Haematol. 1994;86:203-206.
19. Levine RF, Hazzard KC, Lamberg JD. The significance of megakaryocyte size. Blood. 1982;60:1122-1131.
20. Kobayashi Y, Kimura S, Tanaka K, et al. Shift in the megakaryocyte ploidy in MDS patients: microcytofluorometry with DAPI staining after destaining of Wright-Giemsa stain. Br J Haematol. 1991;79:556-561.
21. Kwong YL, Robertson EP, Lee CP, et al. Dual-color flow cytometric analysis of megakaryocytic DNA ploidy in the investigation of blastic phase chronic myelogenous leukemia with rearrangement of 3q26. Cancer. 1993;71:3882-3887.
22. Matolcsy A, Kálmán E, Pajor L, et al. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia. Leuk Res. 1991;15:887-897.
23. Heim S, Mitelman F, eds. Cancer Cytogenetics. 2nd ed. New York, NY: Alan R. Liss; 1995.
24. Inokuchi K, Nomura T. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia. Leuk Lymphoma. 1993;10:9-15.
25. Stoll DB, Peterson P, Exten R, et al. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. Am J Hematol. 1988;27:77-83.
26. Thiele J, Schneider G, Hoeppner B, et al. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis: features of significance for the diagnosis of primary (essential) thrombocythaemia. Virchows Arch A. 1988;413:407-417.